0001493152-26-007150
SEC filingPetVivo Holdings, Inc. reported a net loss of $2.2 million for Q3 2026 (period ending December 31, 2025), consistent with an operating loss of $2.2 million. Revenue for the quarter was $286 thousand, generating a gross profit of $145 thousand with a gross margin of 50.7%. Operating expenses totaled $2.3 million, dominated by General and Administrative ($1.3 million), Sales and Marketing ($761 thousand), and Research and Development ($323 thousand). The company's cash position decreased by $210 thousand during the quarter to $228 thousand, despite raising $5.1 million in net financing from equity and debt issuances, as operating activities used $4.1 million in cash. Total assets stood at $4.4 million against liabilities of $997 thousand, resulting in stockholders' equity of $3.4 million. The period saw significant non-cash financing activities including $2.0 million in convertible debt conversions and $800 thousand in stock issued for a licensing agreement.
PetVivo Holdings reported a net loss of $2.2 million for the third quarter of fiscal 2026 (period ending December 31, 2025), identical to its operating loss. Revenue for the quarter was $286 thousand, with cost of sales at $141 thousand, yielding a gross profit of $145 thousand. Total operating expenses were $2.3 million, comprising Sales and Marketing ($761 thousand), Research and Development ($323 thousand), and General and Administrative ($1.3 million). Other expenses included a $149 thousand loss on disposal of assets and a $320 thousand unrealized loss on derivative liabilities, partially offset by $26 thousand in other income and $13 thousand in interest income. The net loss available to common stockholders was $2.3 million after accounting for $125 thousand in Series B Preferred Stock dividends.
The filing does not provide segment breakdowns, geographic mix, or specific growth drivers for the $286 thousand in quarterly revenue. Revenue generation appears concentrated, with no disclosed diversification across product lines or regions. The absence of segment data limits analysis of underlying business unit performance or market penetration strategies.
The company achieved a gross margin of 50.7% ($145 thousand gross profit on $286 thousand revenue). Operating margin was deeply negative at -769.2%, reflecting the $2.2 million operating loss relative to revenue. The cost structure is heavily weighted toward operating expenses, which at $2.3 million far exceeded gross profit. No prior period comparisons are provided in the data to assess margin trends.
Operating activities used $4.1 million in cash, primarily due to the $2.2 million net loss adjusted for non-cash items including $1.0 million in stock-based compensation and $937 thousand in amortization of debt discount. Investing activities provided $12 thousand in cash. Financing activities provided $5.1 million, mainly from $4.4 million in preferred stock and warrant proceeds and $1.4 million from common stock and warrant sales. The balance sheet shows total assets of $4.4 million, including $1.4 million in current assets (cash $18 thousand, inventory $605 thousand) and $2.5 million in other assets (licensing agreements $2.4 million). Liabilities total $997 thousand, with $988 thousand current (including $1.6 million in convertible notes payable). Stockholders' equity is $3.4 million, with an accumulated deficit of $99.0 million.
The filing does not contain management guidance, forward-looking statements, strategic priorities, or specific risk factors beyond the presented financial data. No outlook or projections are disclosed in the provided content.